Home About us MoEF Contact us Sitemap Tamil Website  
About Envis
Whats New
Microorganisms
Research on Microbes
Database
Bibliography
Publications
Library
E-Resources
Microbiology Experts
Events
Online Submission
Access Statistics

Site Visitors

blog tracking


 
Journal of Molecular Structure
Volume 1232, 2021, 130036

Synthesis and molecular docking study of new 1,3-oxazole clubbed pyridyl-pyrazolines as anticancer and antimicrobial agents

Kanubhai D.Katariyaa, Dushyanth R.Vennapub, Shailesh R.Shaha

Department of Chemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara-390002, Gujarat, India.

Abstract

The present investigation is in the quest of some novel biologically potent heterocyclic compounds 1-aryl-3-(2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl)-propenones 6(a-e) and [5-aryl-3-(2-{(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl)}-4,5-dihydro-1H-pyrazol-1-yl)]-(pyridin-4-yl)methanone 7(a-e) incorporated with biologically active heterocyclic entities namely oxazole, pyrazoline and pyridine. The structures of all the compounds were elucidated using various spectroanalytical techniques such as FT-IR, 1H NMR, 13C NMR and mass spectrometry. The synthesized compounds were studied for their anticancer activity at the National Cancer Institute (NCI, USA) against 60 cancer cell line panel. Data of anticancer activity study revealed that the compound 6(d) has the highest potency. Furthermore, all the compounds were studied for their in vitro antibacterial and antifungal activities. As documented, all the prepared compounds performed well against these pathogenic strains. Moreover, data acquired from the molecular docking studies are very inspiring with respect to the potential utilization of these compounds to help overcome microbe resistance to pharmaceutical drugs.

Keywords: 1,3-Oxazole, Pyridyl-Pyrazoline, Chalcone, Anticancer screening, Antimicrobial activity.

Copyright © 2005 ENVIS Centre ! All rights reserved
This site is optimized for 1024 x 768 screen resolution